Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CS 2100 is a sphingosine-1-phosphate receptor 1 (S1P1) agonist.1,2 It selectively induces GTPγS binding in CHO-K1 cells expressing human or rat S1P1 (EC50s = 4 and 1.5 nM, respectively) over those expressing human or rat S1P3 (EC50s = >20 and 7.4 µM, respectively).1 CS 2100 (0.1 and 1 mg/kg) transiently reduces blood lymphocyte levels in rats with the levels returning to baseline within 24-48 hours. It reduces hind paw volume in a rat model of adjuvant-induced arthritis (ID50 = 0.44 mg/kg). CS 2100 (0.3 and 1 mg/kg) also decreases severity in a mouse model of experimental autoimmune encephalomyelitis (EAE).
WARNING This product is not for human or veterinary use.
1. Discovery of CS-
2. Synthesis and evaluation of CS-